Available online at www.sciencedirect.com ScienceDirect Mackenzie L Lauro, Jason M Burch and Catherine Leimkuhler Grimes Recent advancements toward the treatment of Crohn’s Recognizing this issue, attention has turned to probing disease (CD) indicate great promise for long-term remission. the interactions between the host and microbiome. Ge- CD patients suffer from a complex host of dysregulated netic predisposition is highly correlated to the onset of interactions between their innate immune system and CD. Speciﬁcally, mutations to the innate immune recep- microbiome. The most predominant link to the onset of CD is a tor nucleotide-binding oligomerization domain-contain- genetic mutation in the innate immune receptor nucleotide- ing 2 (NOD2) are the strongest genetic factor in the binding oligomerization domain-containing 2 (NOD2). NOD2 advancement of CD and development of an aggressive responds to the presence of bacteria and stimulates the phenotype [3 ]. NOD2 variants contribute to various immune response. Mutations to NOD2 promote low diversity aspects of the pathogenesis. CD patients with NOD2 and dysbiosis in the microbiome, leading to impaired mucosal mutations possess a distinct and compromised microbial barrier function. Current treatments suppress the immune composition that allows harmful bacteria to thrive [4 ]. In response rather than enhancing the function
Current Opinion in Biotechnology – Elsevier
Published: Aug 1, 2016
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud